Sign In
BDX.US

Becton, Dickinson and Company (BDX) $85M Shareholder Settlement

D. New Jersey
Court
2:20-cv-02155
Case number
05 Nov 2019
Class period Start
05 Feb 2020
Class period End
14 Jun 2024
Claim deadline
Becton, Dickinson and Company (BDX) settled $85 million with investors to end litigation over software errors with Alaris infusion pumps.
Alleged Offence
Misleading Statements
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
2.14
Filing date
27 February 2020
Lead Plaintiff Deadline
27 April 2020
Plaintiffs
Industriens Pensionsforsikring A/S
Attorneys
Carella, Byrne, Cecchi, Olstein, Brody & Agnello, P.C. (Roseland, NJ), Kessler Topaz Meltzer & Check LLP (Radnor, PA)
Defendants
Vincent Forlenza, Thomas Polen, Christopher Reidy
Judge
Hon. Stanley R. Chesler
Administrator
JND Legal Administration
Court hearing date
22 April 2024
Exclusion deadline
01 April 2024
Objection deadline
01 April 2024
Class wide damages
$738,600,000
Trades matching type
FIFO
+$85,000,000
Total Settlement Amount
Created by Stan Vick, Scout

Becton Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science resear...

    Ticker
    BDX.US
    ISIN
    US0758871091
    CIK
    10795
    Sector
    Healthcare
    Industry
    Medical Instruments & Supplies
    Country
    USA
    Address
    1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880